Ulcerative Colitis
JNJ-77242113 (ANTHEM-UC)
Clinical Research Study
Do you have moderate to severe ulcerative colitis and are currently experiencing symptoms? If so, you might be eligible to participate in a clinical trial. Register now to find out if you qualify for this study.
Before determining if you're a suitable candidate for this study, a study physician will review your medical history and perform some additional health assessments. You could be eligible to participate in the JNJ-77242113 Study if you meet the following criteria:
-
18 years of age or older
-
Documented diagnosis of ulcerative colitis (UC) of at least 12 weeks prior to screening
-
Diagnosis of UC established at least 12 weeks prior to Screening by standard clinical and endoscopic evidence and corroborated by a histopathology report.
-
Moderately to severely active UC as per the modified Mayo score
-
Demonstrated inadequate response to or intolerance of conventional therapy and/or advanced therapy as defined in the protocol
For further details about the JNJ-77242113 Ulcerative Colitis Clinical Study, please complete the Signup Form available here. Rest assured, your personal information will be handled in accordance with HIPAA regulations, ensuring your privacy is protected.
What Does a Clinical Research Study Entail?
A clinical research study is a carefully designed investigation aimed at exploring specific aspects of potential new medications, often referred to as "investigational drugs." This includes evaluating the safety and efficacy of these drugs for treating certain conditions or diseases.
Every drug prescribed by healthcare professionals has been through extensive testing in clinical research studies. These studies are crucial for medical progress, as they pave the way for the development and availability of new treatments.
Deciding to participate in a clinical research study is significant, and it's entirely up to you. It's essential to fully understand what your involvement would entail before you commit to participating.